Company intelligence / Profile preview

Mizuho Securities

Ownership: Private
Employees: ~6485
Development stage: Other

Overview

Mizuho Securities is a leading Japanese investment banking and securities firm, providing financial instruments business services including bond and stock trading, debt and equity financing, structured finance advisory, and research coverage for various sectors including healthcare and biotechnology. It does not develop drugs or therapeutics itself but plays a significant role in financing life science companies.

Industry: Investors

Partnerships

Mizuho acts as bookrunner/underwriter for major healthcare/biotech financings but does not have traditional pharma partnerships. Recent deals include work with Thermo Fisher, Medtronic, Amgen, Envista, GE HealthCare

Beyond the preview

Go deeper on Mizuho Securities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mizuho Securities.

Explore the full profile